Related Experiment Video
Updated: May 11, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
[Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?]
1KU Leuven, Leuven, België. dr.e.holvoet@gmail.com
Insights
Melatonin may effectively treat sleep onset insomnia in children with ADHD. However, more research is needed to confirm its safety and establish clear dosage guidelines for pediatric use.
Area of Science:
- Pediatric Sleep Medicine
- Neurodevelopmental Disorders
- Pharmacology
Context:
- Sleep disorders are prevalent in children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
- Stimulant medications commonly used for ADHD can exacerbate sleep disturbances.
- Chronic sleep onset insomnia (CSOI) affects a significant portion of children with ADHD.
Purpose:
- To evaluate the efficacy and safety of melatonin for treating sleep disorders in children with ADHD.
- To review existing literature on melatonin's use in this pediatric population.
Summary:
- Melatonin shows promise in treating CSOI in children with ADHD and is generally well-tolerated.
- Current research indicates a need for standardized melatonin preparations and evidence-based dosing guidelines for pediatric use.
- Limited data exists on melatonin's long-term effects on puberty and the endocrine system in children.
Impact:
- Melatonin may be a viable option for persistent insomnia in children with ADHD impacting daily function, especially with circadian rhythm phase shifts.
- Further rigorous research is essential to ascertain the safety profile of melatonin in pediatric ADHD patients.
- This review highlights the need for evidence-based guidelines to support the clinical use of melatonin in pediatric ADHD.
Background:
Sleep disorders are common in children with ADHD and they are aggravated by treatment with stimulantia. We focus on treatment with melatonin and weigh up its efficacy and safety.
Aim:
To consider the evidence supporting the use of melatonin in the treatment of children with ADHD and to assess the efficacy and safety of such treatment.
Method:
We studied the literature using databases Embase, PubMed, PsycINFO and the Cochrane Library and the search terms 'ADHD', ‘melatonin', ‘insomnia', ‘methylphenidate', ‘side-effects', ‘endocrinology'.
Results:
25-50% of children with ADHD reported disturbed sleep patterns particularly in the form of (chronic) sleep onset insomnia ((C)SOI). Currently available research results indicate that melatonin can be effective in the treatment of (C)SOI and, on the whole, is well tolerated. However, there is a lack of pharmaceutical preparations of melatonin that give details about their use for children and that give evidence-based guidelines about the dosage and timing of intake. Very little systematic research has been done into the possible impact of melatonin intake on puberty and the endocrine system. Therefore, treatment with melatonin in children with ADHD and (C)SOI is best reserved for children with persistent insomnia which is having a severe impact on daily functioning, particularly in cases where is an obvious phase-shift of the endogenous circadian rhythm.
Conclusion:
If indications are particularly strong there may be good reason to use melatonin to treat sleep disorders in children with ADHD. However, further research into the safety of melatonin is needed.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
08:45Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Insomnia
Multiple factors contribute...
Narcolepsy